| P2093 | author name string | Durso R | |
| | Evans B | |
| | Browne TR | |
| | Evans JE | |
| | Szabo G | |
| | Fernandez HH | |
| | Josephs E | |
| P2860 | cites work | Homovanillic acid measurement in clinical research: a review of methodology | Q22242836 |
| | Benefits of monitoring plasma levodopa in Parkinson's disease patients with drug-induced chorea | Q28333107 |
| | Catechol-O-methyltransferase inhibition with tolcapone reduces the "wearing off" phenomenon and levodopa requirements in fluctuating parkinsonian patients | Q36317207 |
| | Levodopa and decarboxylase inhibitors: a review of their clinical pharmacology and use in the treatment of parkinsonism | Q40575022 |
| | Peripheral Pharmacokinetic Handling and Metabolism of L-Dopa in the Rat: The Effect of Route of Administration and Carbidopa Pretreatment | Q44843262 |
| | Routes of administration and effect of carbidopa pretreatment on 6-[18F]fluoro-L-dopa/PET scans in non-human primates | Q49195168 |
| | L-dopa decarboxylation in chronically treated patients | Q64762170 |
| | Tolcapone improves motor function in parkinsonian patients with the "wearing-off" phenomenon: a double-blind, placebo-controlled, multicenter trial | Q64955113 |
| | Tolcapone improves motor function and reduces levodopa requirement in patients with Parkinson's disease experiencing motor fluctuations: a multicenter, double-blind, randomized, placebo-controlled trial. Tolcapone Fluctuator Study Group I | Q67220188 |
| | Further studies on catechol uptake and metabolism in rat small bowel in vivo: (1) a quantitatively significant process with distinctive structural specifications; and (2) the formation of a dopamine glucuronide reservoir after chronic L-dopa feeding | Q67389196 |
| | High-performance liquid chromatographic method for measuring homovanillic acid in cerebrospinal fluid using electrochemical detection with internal standardization | Q68014062 |
| | Effects of peripheral aromatic l-amino acids decarboxylase inhibitor on L-[2-14C]-3,4-dihydroxy-phenylalanine metabolism in man | Q69401748 |
| | Magnitude of response to levodopa in Parkinson disease as it relates to peripheral and central measurements of levodopa and associated metabolites | Q69425315 |
| | Determination of acidic catecholamine metabolites in plasma and cerebrospinal fluid using gas chromatography-negative-ion mass spectrometry | Q69664522 |
| | Pharmacokinetics of Levodopa | Q70331163 |
| | L-3,4-dihydroxyphenylalanine metabolism by the gut in vitro | Q70633440 |
| | Aromatic l-amino acid decarboxylase activity in central and peripheral tissues and serum of rats with l-dopa and l-5-hydroxytryptophan as substrates | Q70899887 |
| | Enzymes related to monoamine transmitter metabolism in brain microvessels | Q72440344 |
| P433 | issue | 8 | |
| P921 | main subject | levodopa | Q300989 |
| | (S)-(−)-carbidopa monohydrate | Q414225 |
| P304 | page(s) | 854-860 | |
| P577 | publication date | 2000-08-01 | |
| P1433 | published in | The Journal of Clinical Pharmacology | Q7743562 |
| P1476 | title | Variable absorption of carbidopa affects both peripheral and central levodopa metabolism | |
| P478 | volume | 40 | |